药物难治性癫痫颞叶切除术后的30天术后发病率与死亡率
基于2006至2014年多机构手术登记库的回顾性队列分析,纳入216例因药物难治性癫痫行前颞叶切除术和/或杏仁核海马切除术的患者,30天死亡率为1.4%,至少发生一项主要并发症者占6.5%,再入院率为11%。多变量回归显示年龄增长是出院去向非家庭的独立预测因素,男性是发生主要并发症的显著危险因素。
要点
- 216例颞叶切除术患者30天死亡率为1.4%,主要并发症率为6.5%。
- 2011至2014年155例中再入院率为11%,出院去向非家庭者占10.3%。
- 术中主治神经外科医师与住院医师同时在场与延长住院和出院去向非家庭的 odds 降低显著相关。
核心结论
- 基于多机构手术登记库,药物难治性癫痫颞叶切除术的30天死亡率为1.4%,主要并发症率为6.5%,再入院率为11%。
- 颞叶切除术对起源于该部位的癫痫是极为有效的治疗,但手术干预必须权衡其发病率与死亡率结局。
研究设计与样本
- 回顾性队列分析,使用2006至2014年间编制的多机构手术登记库。
- 纳入因药物难治性癫痫行前颞叶切除术和/或杏仁核海马切除术的患者,共216例。
- 采用单变量和多变量分析,涉及患者人口学、合并症、手术特征和30天结局。
主要发现
- 中位年龄38岁,46%为男性,中位住院时间3天。
- 30天死亡率为1.4%,14例(6.5%)发生至少一项主要并发症,7例(3.2%)重返手术室。
- 2011至2014年(n=155)30天内再入院率为11%,出院去向非家庭者为10.3%。
- 多变量回归显示年龄增长是出院去向非家庭的独立预测因素,男性是发生主要并发症的显著危险因素。
- 术中主治神经外科医师与住院医师同时在场与延长住院(即>75百分位[5天])和出院去向非家庭的 odds 降低显著相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE Temporal lobectomy is a well-established treatment modality for the management of medically refractory epilepsy in appropriately selected patients. The aim of this study was to assess 30-day morbidity and mortality after temporal lobectomy in cases registered in a national database. METHODS A retrospective cohort analysis was conducted using a multiinstitutional surgical registry compiled between 2006 and 2014. The authors identified patients who underwent anterior temporal lobectomy and/or amygdalohippocampectomy for a primary diagnosis of intractable epilepsy. Univariate and multivariable analyses with regard to patient demographics, comorbidities, operative characteristics, and 30-day outcomes were applied. RESULTS A total of 216 patients were included in the study. The median age was 38 years and 46% of patients were male. The median length of stay was 3 days and the 30-day mortality rate was 1.4%. Fourteen patients (6.5%) developed at least one major complication. Return to the operating room was observed in 7 patients (3.2%). Readmission within 30 days and discharge to a location other than home were available for 2011-2014 (n = 155) and occurred in 11% and 10.3% of patients, respectively. Multivariable regression analysis revealed that increasing age was an independent predictor of discharge disposition other than home and that male sex was a significant risk factor for the development of a major complication. Interestingly, the presence of the attending neurosurgeon and a resident during the procedure was significantly associated with decreased odds of prolonged length of stay (i.e., > 75th percentile [5 days]) and discharge to a location other than home. CONCLUSIONS Using a multiinstitutional surgical registry, 30-day outcome data after temporal lobectomy for medically intractable epilepsy demonstrates a mortality rate of 1.4%, a major complication rate of 6.5%, and a readmission rate of 11%. Temporal lobectomy is an extremely effective therapy for seizures originating there-however, surgical intervention must be weighed against its morbidity and mortality outcomes.
引用
- Kerezoudis P, McCutcheon B, Murphy ME, et al. Thirty-day postoperative morbidity and mortality after temporal lobectomy for medically refractory epilepsy. J Neurosurg. 2017. PMID: 28644097. doi:10.3171/2016.12.JNS162096
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。